X-linked agammaglobulinemia (XLA) is a genetic immunodeficiency disorder characterized by the absence of antibodies in the blood, leading to increased susceptibility to infections. This condition is caused by mutations in the BTK gene, which is essential for B-cell development, and it primarily affects males. Understanding XLA is crucial for recognizing how certain genetic conditions can lead to depressed immune responses, resulting in significant health challenges for affected individuals.